Zhu et al. [164] also showed that blockade of CSF-1/CSF-1R signaling in pancreatic tumors depletes CD206High TAM and reprograms remaining macrophages to support antitumor immunity. The gene discussed is CSF1; the disease is pancreatic neoplasm.